MogaMu lizumab [CAS 1159266-37-1]
Partner: MedChemexpress LLC
| CAS No: | 1159266-37-1 |
| Applications: | COVID-19-anti-virus |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Mogamulizumab] |
| Purity: | 95.00 |
| Description: | Mogamulizumab (KW-0761) is a defucosylated humanized recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL)[1][2][3]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
